Compare Kinder Morgan Inc (KMI) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kinder Morgan Inc vs Revvity Inc — how do they compare? Kinder Morgan Inc trades at $32.21 (market cap $72.48B), while Revvity Inc trades at $110.17 (market cap $11.87B). The key difference: Kinder Morgan Inc is far larger — about 6.1× Revvity Inc's market cap, and Kinder Morgan Inc pays the higher dividend (3.61%). Which is the better fit depends on your goals.
| KMI | RVTY | |
|---|---|---|
Market Cap | $72.48B | $11.87B |
Sector | Energy | Technology |
52-Week High | $34.31 | $117.75 |
52-Week Low | $25.84 | $82.26 |
Enterprise Value | $104.36B | $14.36B |
Dividend Yield | 3.61% | 0.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kinder Morgan (KMI) trades at $32.71, up 1.27% with neutral technical signals. The company shows strong fundamentals with revenue growth from $15.1B in 2024 to $16.9B in 2025 and net income margin improving to 18.04%. Recent Q1 2026 earnings beat expectations with $0.48 EPS versus $0.40 expected. KMI maintains a $10.1B project backlog focused on natural gas infrastructure, supporting future growth. Analyst sentiment is mixed with 47% buy ratings but technical indicators show neutral momentum near key support at $32.
KMI presents a balanced opportunity with stable cash flows from fee-based contracts and dividend yield near 4%. Upside potential exists from LNG export growth and power demand, though valuation appears fair at P/E of 21.7. Key risks include commodity price exposure and high debt levels at $29.7B long-term. The stock offers income stability but limited near-term catalysts given neutral technical positioning.
RVTY trades at $106.44, down 3.37% today, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 4, 2026. Recent developments include AI integration partnerships and FDA clearances, supporting growth in its diagnostics and life sciences segments. Valuation metrics show a P/E of 52.96 and P/S of 4.35, reflecting premium pricing for its growth prospects.
The stock presents a balanced opportunity with analyst consensus pointing to 4.7% upside to the $111.43 price target. Strong institutional ownership and zero sell ratings indicate confidence, though high valuation multiples and negative cash flow trends pose risks. Earnings momentum from recent beats and strategic AI expansions provide catalysts, but investors should monitor margin pressures and China market exposure highlighted in recent quarters.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
